Parameters including displayed increased localization of CD8+ T cells to the tumor core, and increased expression of check-point regulators such as PD-L1 expression on tumor stroma have been shown to correlate with positive disease response to ICI (126, 128). This evidence concerns the gene CD8A and neoplasm.